Literature DB >> 9916804

Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

D J Marsh1, G Hollopeter, D Huszar, R Laufer, K A Yagaloff, S L Fisher, P Burn, R D Palmiter.   

Abstract

Mutations reducing the functional activity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and the melanocortin-4 receptor (Mc4r) all lead to obesity in mammals. Moreover, mutant mice that ectopically express either agouti (Ay/a mice) or agouti-related protein (Agrp), antagonists of melanocortin signalling, become obese. These data suggest that alpha-MSH signalling transduced by Mc4r tonically inhibits feeding; however, it is not known to what extent this pathway mediates leptin signalling. We show here that Mc4r-deficient (Mc4r-/-) mice do not respond to the anorectic actions of MTII, an MSH-like agonist, suggesting that alpha-MSH inhibits feeding primarily by activating Mc4r. Obese Mc4r-/-mice do not respond significantly to the inhibitory effects of leptin on feeding, whereas non-obese Mc4r-/- mice do. These data demonstrate that melanocortin signalling transduced by Mc4r is not an exclusive target of leptin action and that factors resulting from obesity contribute to leptin resistance. Leptin resistance of obese Mc4r-/- mice does not prevent their response to the anorectic actions of ciliary neurotrophic factor (CNTF), corticotropin releasing factor (CRF), or urocortin; or the orexigenic actions of neuropeptide Y (NPY) or peptide YY (PYY), indicating that these neuromodulators act independently or downstream of Mc4r signalling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916804     DOI: 10.1038/5070

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  135 in total

1.  Circumventing leptin resistance for weight control.

Authors:  S P Kalra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors.

Authors:  L Ste Marie; G I Miura; D J Marsh; K Yagaloff; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism.

Authors:  Sonja K Billes; Stephanie E Simonds; Michael A Cowley
Journal:  Mol Metab       Date:  2012-07-27       Impact factor: 7.422

4.  Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhengwei Cai; Shuying Lin; John H Dubinion; John E Hall
Journal:  Hypertension       Date:  2011-03-21       Impact factor: 10.190

5.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 6.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

7.  Dmbx1 is essential in agouti-related protein action.

Authors:  Wakako Fujimoto; Tetsuya Shiuchi; Takashi Miki; Yasuhiko Minokoshi; Yoshihisa Takahashi; Ayako Takeuchi; Kazuhiro Kimura; Masayuki Saito; Toshihiko Iwanaga; Susumu Seino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

8.  Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP.

Authors:  Michael J Krashes; Bhavik P Shah; Shuichi Koda; Bradford B Lowell
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

9.  Centrally administered orexin A increases motivation for sweet pellets in rats.

Authors:  A J Thorpe; J P Cleary; A S Levine; C M Kotz
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 10.  Leptin signaling and leptin resistance.

Authors:  Yingjiang Zhou; Liangyou Rui
Journal:  Front Med       Date:  2013-04-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.